Dual antiplatelet therapy after coronary artery bypass surgery

被引:2
|
作者
Sandner, Sigrid [1 ,2 ]
机构
[1] Med Univ Vienna, Dept Cardiac Surg, Vienna, Austria
[2] Weill Cornell Med, Dept Cardiothorac Surg, New York, NY 10021 USA
来源
关键词
PATENCY; 1; YEAR; GRAFT PATENCY; ASSOCIATION; PREVENTION; TICAGRELOR; OUTCOMES; ASPIRIN;
D O I
10.1136/bmj.q1083
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [31] ANTIPLATELET THERAPY AFTER CORONARY ARTERY BYPASS GRAFT SURGERY - UNEVENNESS OF DAILY CLINICAL PRACTICE
    Merkas, Ivana Sopek
    Lakusic, Nenad
    Fuckar, Krunoslav
    Cerovec, Dusko
    Besic, Kristina Maric
    ACTA CLINICA CROATICA, 2021, 60 (03) : 540 - 543
  • [32] Sudden cardiac death after coronary artery bypass graft surgery and role of antiplatelet therapy
    Ch, Iftikhar Ali
    Chaudhry, Azhar
    Zehra, Mishal
    Wu, Pei-Tzu
    Tahirkheli, Mashal
    Bai, Poonam
    Bhaktaram, Ananya
    Jamal, Rahat
    Chaudry, Sabrina
    Amil, Faris
    Randolph, John
    Miller, Steven
    Garrett, Jeffrey
    Tahirkheli, Naeem
    PLOS ONE, 2025, 20 (02):
  • [33] The impact of dual antiplatelet therapy administration on the risk of bleeding complications during coronary artery bypass surgery
    Nardi, Paolo
    Pisano, Calogera
    Turturici, Maria
    Bertoldo, Fabio
    Maggio, Vito Renato
    Bassano, Carlo
    Buioni, Dario
    Scafuri, Antonio
    Altieri, Claudia
    Ruvolo, Giovanni
    KARDIOCHIRURGIA I TORAKOCHIRURGIA POLSKA-POLISH JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2021, 18 (03) : 145 - 151
  • [34] Impact of dual antiplatelet therapy after coronary artery bypass surgery on 1-year outcomes in the Arterial Revascularization Trial
    Benedetto, Umberto
    Altman, Douglas G.
    Gerry, Stephen
    Gray, Alastair
    Lees, Belinda
    Flather, Marcus
    Taggart, David P.
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2017, 52 (03) : 456 - 461
  • [35] Efficacy and Safety of Dual Antiplatelet Therapy on Graft Patency After Coronary Artery Bypass Graft Surgery: A Randomized Controlled Trial
    Abdi, Seifollah
    Momtahen, Mahmood
    Bassiri, Hossein-Ali
    Shafiei, Ali
    Sadeghipour, Parham
    Madani, Mohsen
    Bakhshandeh, Hooman
    IRANIAN HEART JOURNAL, 2020, 21 (01): : 6 - 16
  • [36] DUAL VERSUS SINGLE ANTIPLATELET THERAPY AFTER CORONARY ARTERY BYPASS GRAFTING: A META-ANALYSIS
    Agrawal, Ankit
    Kumar, Ashwin
    Wang, Tom Kai Ming
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2022, 79 (09) : 1114 - 1114
  • [37] A systematic review of guidelines for dual antiplatelet therapy in coronary artery bypass graft
    Zhang, Zheng-zhi-peng
    Zhang, Shao-zhao
    Zhou, Hui-min
    Fan, Yong-qiang
    Liu, Meng-hui
    Zhong, Xiang-bin
    Yang, Da-ya
    Guo, Yue
    Zhuang, Xiao-dong
    Liao, Xin-xue
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2021, 51 (01)
  • [38] BLEEDING RISK AFTER CORONARY ARTERY BYPASS GRAFTING: DOES THE DUAL ANTIPLATELET THERAPY REGIMEN MATTER?
    Bolaji, Olayiwola
    Unamba, Uchenna D.
    Soji-Ayoade, Demilade A.
    Akinwale, Mariam
    Shittu, Muhammed
    CHEST, 2022, 162 (04) : 249A - 249A
  • [39] Dual-Antiplatelet Therapy After Coronary Artery Bypass Grafting: A Survey of UK Cardiac Surgeons
    Comanici, Maria
    Raja, Shahzad G.
    JOURNAL OF CARDIOTHORACIC AND VASCULAR ANESTHESIA, 2023, 37 (12) : 2517 - 2523
  • [40] Antiplatelet Therapy Before Coronary Artery Bypass Surgery. Is the Bridging Therapy Possible?
    Altarev, S.
    Barbarash, O.
    KARDIOLOGIYA, 2014, 54 (07) : 85 - 91